Analysis of data generated by insulin pump using LabVIEW environment

• Autorzy: Matejko B.
• Języki publikacji: EN

Abstrakty

EN

Diabetes mellitus is a group of metabolic diseases characterized by impaired insulin secretion or action affecting around 200 million people worldwide. Type 1 diabetes makes up 10% of all diabetes cases. Currently, the most physiological way of insulin delivery involves the use of an insulin pump, which administers insulin in a continuous manner. During an outpatient visit insulin pump data are read and analyzed to optimize treatment and improve patients metabolic control. There are commercial software companies producing insulin pumps which present data in a report format. The aim of this project was to write a program in a LabVIEW environment which would analyze the insulin pump data. The program includes structured bookmarks, statistics on glucose (different systems of measurement), insulin, nutritional information, uses advanced tools in the pump, and presents the entire recorded history of pump data (commercial version statistics use only two week time intervals). Implemented as an innovative feature that compares the blood glucose meter to indicate the continuous glucose monitoring system. The software built for this purpose can be used in diabetes clinics to analyze insulin pump data and to research on the application of new diabetes technology. The current version can be treated as a foundation for possible further expansion of the program functionality.

Słowa kluczowe

EN

diabetes; insulin pump; CareLink Medtronic

• Wydawca: Uniwersytet Jagielloński - Collegium Medicum ; Index Copernicus Sp. z o.o.
• Czasopismo: Bio-Algorithms and Med-Systems
• Rocznik: 2011
• Tom: Vol. 7, no. 4
• Strony: 79--82
• Opis fizyczny: Bibliogr. 19 poz., rys.

Twórcy

autor

Matejko B.

• Multidisciplinary School of Engineering in Biomedicine, AGH- University of Science and Technology, Kraków, Poland
• Department of Metabolic Diseases, Jagiellonian University Medical College, 15 Kopernika St., Kraków, Poland

Bibliografia

• 1. World Health Organization, International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, World Health Organization Document Production Services, 2006
• 2. Yach D., Stuckler D., Brownell K.: Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nature Medicine. 2006; 12(1): 62-66.
• 3. Korzeniowska K., Jabłecka A.: Cukrzyca (Część I), Diabetes (Part I). Farmacja Współczesna. 2008, 1: 231-235.
• 4. 14 listopada- Światowy Dzień Walki z Cukrzycą, http://http://naukawpolsce.pap.pl/palio/html.run?_Instance=cms_naukapl.pap.pl&_PageID=1&s=szablon.depesza&dz=szablon.depesza&dep=367789&data=&lang=PL&_CheckSum=1213615981 (2011 Jul 21).
• 5. Diabetes Control and Complications Trial. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N. Engl. J Med. 1993, (329): 977-986.
• 6. Jeitler K, Horvath K., Berghold A. et al. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia. 2008, 51(6): 941-51.
• 7. Pickup J.C. , Sutton A.J.: Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabetic medicine: a Journal of the British Diabetic Association 2008, 25(7): 765-774.
• 8. Pickup J.K.H.: Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002, 25(3): 593–598.
• 9. Bruttomesso D., Costa S., Baritussio A.: Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy. Diabetes/metabolism research and reviews 2009, 25(2): 99-111.
• 10. Aberle I., Zimprich D., Bach-Kliegel B., Fischer C. et al.: Continuous subcutaneous insulin infusion leads to immediate, stable and long-term changes in metabolic control. Diabetes, obesity & metabolism 2008; 10(4): 329-335.
• 11. Jankovec Z., Hahn M., Grunder S. et al.: Analysis of continuous patient data from the Czech National Register of patients with type 1 and type 2 diabetes using insulin pump therapy. Diabetes research and clinical practice 2010, 87(2): 219-223.
• 12. Phillip M , Battelino T , Rodriguez H , et al.: Use of insulin pump therapy in the pediatric age-group: consensuc statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2007, 30: 1653-1662.
• 13. ADA Clinical Practice Recommendations, Diabetes Care 2000, 23 (suppl.)
• 14. Care Link Professional, http://www.medtronic.com/for-healthcare-professionals/products-therapies/diabetes/diabetes-management-software (2011 Sep 21).
• 15. Accu Chek 360, http://www.accu-chek.pl/pl/produkty/zarzadzaniedanymi/360.html (2011 Sep 21).
• 16. Dana manager, http://www.sooil.com/NEW/eng/m3_ma_00.html (2011 Sep 21).
• 17. Product Information: What is NI LabVIEW? http://www.ni.com/labview/whatis/ (2011 Sep 21).
• 18. Strona producenta oprogramowania LabView, http://poland.ni.com/ (2011 Sep 21).
• 19. Chruściel M.: LabVIEW w praktyce. Legionowo: Wydawnictwo BTC, 2008.